Tango Therapeutics (TNGX) Other Working Capital Changes (2020 - 2026)

Tango Therapeutics' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 394.74% year-over-year to $2.3 million in Q1 2026; TTM through Mar 2026 was -$59.3 million, a 7406.96% decrease from a year earlier, with the FY2025 full-year figure at -$62.4 million, down 16760.54% from the prior year.
• Other Working Capital Changes grew to $2.3 million in Q1 2026 per TNGX's latest filing, from -$60.8 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $8.8 million in Q3 2022 and bottomed at -$60.8 million in Q3 2025.
• The 5-year median for Other Working Capital Changes is -$376000.0 (2023), against an average of -$4.7 million.
• Across the five-year window, Other Working Capital Changes soared 1091.13% in 2022 and tumbled 4174.4% in 2025, its largest moves.
• Year by year, Other Working Capital Changes stood at -$18.2 million in 2022, then jumped by 122.44% to $4.1 million in 2023, then slumped by 84.4% to $636000.0 in 2024, then tumbled by 9658.18% to -$60.8 million in 2025, then surged by 103.78% to $2.3 million in 2026.
• Per Business Quant, the three latest TNGX Other Working Capital Changes figures stand at $2.3 million (Q1 2026), -$60.8 million (Q3 2025), and -$814000.0 (Q2 2025).